Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence

Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence

Bibliographic Details
Main Authors:	Konstantinos Tselios, Panagiotis Skendros
Format:	Article
Language:	English
Published:	AVES Yayincilik 2020-08-01
Series:	European Journal of Rheumatology
Online Access:	https://www.eurjrheumatol.org/en/hydroxychloroquine-against-covid-19-a-critical-appraisal-of-the-existing-evidence-133319

Similar Items

COVID-19: Critical appraisal of the evidence
by: Paz González Rodríguez, et al.
Published: (2021-09-01)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed
by: Rachid Tahiri Joutei Hassani, et al.
Published: (2020-06-01)

Utility of hydroxychloroquine for COVID-19: Are we hoping against hope?
by: K C Manish, et al.
Published: (2021-01-01)

Hydroxychloroquine, COVID-19, and prophylaxis
by: Viroj Wiwanitkit
Published: (2020-01-01)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
by: Mondher Toumi, et al.
Published: (2020-01-01)

Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
by: Christian A. Devaux, et al.
Published: (2021-02-01)

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic
by: Serena Romani, et al.
Published: (2021-01-01)

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01)

Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01)

Chronic Brucellosis Patients Retain Low Frequency of CD4+ T-Lymphocytes Expressing CD25 and CD28 after Escherichia coli LPS Stimulation of PHA-Cultured PBMCs
by: Panagiotis Skendros, et al.
Published: (2008-01-01)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01)

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
by: Yogesh Acharya, et al.
Published: (2020-08-01)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
by: Nicholas J White, et al.
Published: (2020-09-01)

Cardiovascular safety of hydroxychloroquine: Brief appraisal of data
by: Anil Pareek, et al.
Published: (2021-01-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
by: Nour K. Younis, et al.
Published: (2020-11-01)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
by: Alter, S., et al.
Published: (2022)

Role of hydroxychloroquine in multidrug treatment of COVID-19
by: Peter A. McCullough, et al.
Published: (2021-09-01)

Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
by: Abdalla Salem Elhwuegi
Published: (2020-01-01)

Safety and efficacy of Hydroxychloroquine and Chloroquine in treatment of COVID-19: A rapid review of evidence
by: Elham Khatooni, et al.
Published: (2020-10-01)

Therapeutic status of hydroxychloroquine in COVID-19: A review
by: Kirandeep Kaur, et al.
Published: (2020-01-01)

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
by: S. G. P. Funnell, et al.
Published: (2020-08-01)

Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
by: PLOS Medicine Staff
Published: (2020-10-01)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
by: Rosa Camila Lucchetta, et al.
Published: (2020-04-01)

Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
by: Ahmet Burak Dirim, et al.
Published: (2020-10-01)

Ethical Considerations of Hydroxychloroquine During the COVID-19 Pandemic
by: Amy Reese
Published: (2021-08-01)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
by: Atiya R Faruqui, et al.
Published: (2021-01-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
by: Carlos Enrique Salgado-Fuentes
Published: (2021-05-01)

When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?
by: Dimitrios P. Bogdanos, et al.
Published: (2019-01-01)

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
by: Belayneh A
Published: (2020-09-01)

A critical appraisal of Covid-19 in Malaysia and beyond
by: Abdullah, Jafri Malin, et al.
Published: (2020)

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
by: B G Manjunath, et al.
Published: (2020-01-01)

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19
by: Vasilios M. Polymeropoulos
Published: (2020-04-01)

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
by: Mark Stewart, et al.
Published: (2021-01-01)